WCCT Global Clinical Research Executive Team

Kenneth T. Kim


Dr. Kenneth Kim, a summa cum laude graduate of Harvard College, received his MD from Harvard Medical School. Following a fellowship at the MIT Sloan School of Management, he completed his internal medicine and allergy/immunology training at UCLA. He is the founder and CEO of WCCT Global LLC, an early phase drug development clinical CRO, based in the United States with 2 CPU’s with 180 beds and 3 research site locations. Dr. Kim has served as a medical monitor, consultant, or investigator on over 500 clinical trials, having published over 30 research articles and 50 abstracts in peer reviewed journals. He has presented to the FDA on challenges and strategies of dose selection and study design for pediatric trials and met key decision makers at the PMDA, SFDA, and KFDA. He has spoken at multiple national and international meetings and is a well recognized expert in the areas of clinical pharmacology, ethnobridging, and respiratory and allergic diseases.

Jon Rojas


Mr. Rojas has over 12 years of clinical research experience (having conducted over 1500 trials) in the CRO industry.

Prior to joining West Coast Clinical Trials, LLC (WCCT), Mr. Rojas served as Sr. Vice President of Clinical Services & Support at OmniComm. In his role there, he managed global teams that designed, implemented and supported all of the clinical trial management (EDC) systems. In addition, part of his responsibilities included expanding global project management as Vice President of Project Management. Prior to working for OmniComm, Mr. Rojas was Executive Director of Clinical Operations at SFBC International (now doing business as PharmaNet Development Group, Inc.). Mr. Rojas was responsible for managing a 500+ bed clinical research unit with over 700 employees. In addition to clinical operations; Mr. Rojas implemented project management, clinical trial management, clinical trial monitoring, SOP and training functions. Mr. Rojas was also the clinical operations manager of a 50 bed QTc specialty unit which performed over a 100 QTc trials.

Mr. Rojas has delivered a multitude of educational presentations at key industry meetings such as DIA, EDC & Beyond and ACRP.

Mel Affrime

Senior Vice President, Translational Medicine

30+ years of clinical research experience
Co-Founder of an Academic Clinical Pharmacology Unit
Served as Chief Scientific Officer for a major global CRO & VP and Global Head of Early Development for two major Pharma companies
Designed and successfully implemented early development programs for more than 15 successfully marketed products

Bill van Nostrand

Executive Vice President, Business Development & Marketing

Bill has over 40 years of experience in the pharmaceutical industry, having founded one of the first ever global late stage CROs, In Vivo, Inc. He has held multiple executive positions in the industry, including: President, Senior Vice President, GM, and Chief Business Officer. Bill is the CEO of his own consulting company, Medical Marketing Solutions. During his time in the industry, he has played a key role in multiple M&A deals for several companies.

Lee Barsky

MBA/MHA, PMP: Vice President, Global Clinical Development

17 years of clinical research experience
Has a balanced perspective, having worked for big pharma, CROs, and specialty research providers
Responsible for the successful design and implementation of 1,000+ clinical trials across multiple therapeutic areas
Expertise in Global Project Management, Clinical Operations/Clinical Development, & Data Management

Edward Kim

Vice President, Early Clinical Development

Ed has over 19 years of experience in the clinical research industry, having conducted over 900 clinical trials including programs in: SAD/MAD, Ethnobridging, CNS, CSF (LP and Serial Collections), Cardiology (TQT, Telemetry, Holter), Ophthalmology, and Sleep Disorders. Ed has served as the Director of Clinical Operations, overseeing all Early Phase operations for a major global CRO, and has managed a 100+ bed clinical pharmacology unit with over 300 employees. Ed has expertise in Clinical Operations, Project Management, and Patient Recruitment.